News

The transaction, which is with three connected entities, also includes GSK divesting a non-core brand and a manufacturing facility in the country. GSK has also divested its Insto

Through these enhancements, Caris Molecular Intelligence will now provide oncologists even more potentially useful treatment information for some of the most challenging cancers, including ovarian, head and neck,

Pergoveris is a combination of recombinant human follicle stimulating hormone (r-hFSH) and recombinant human luteinizing hormone (r-hLH) delivered through subcutaneous injection. The multi-center, randomized, controlled, single-blind, parallel Espart

The approval marks a major step towards providing those who suffer from frequent heartburn broader access to a brand doctors and patients have trusted for years. Pfizer acquired

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) had already issued a positive opinion for Latuda in January 2014. Latuda is an atypical

The topic of the Conference was "Different perspectives – one vision: Better healthcare for patients". The Conference helped professionals in the field of medicines, medical device, medical technology,

The uniqueness of this vaccine is that it is produced in ciliates and covers nearly all variations of a certain parasite antigen – a worldwide novelty. This project

The capacity expansion at the plant will help in providing a reliable supply of high-quality products to meet the domestic demand for the company’s products including cardiovascular and

The prospective, randomized, double-blind, placebo-controlled Phase IIa trial is designed to enroll up about 24 patients with type 1 diabetes in-clinic for ten days. During the trial, patients